BMPER variants associated with a novel, attenuated subtype of diaphanospondylodysostosis.
|
| Abstract |
Diaphanospondylodysostosis (DSD), caused by loss of bone morphogenetic protein-binding endothelial regulator (BMPER), has been considered a lethal skeletal dysplasia characterized by severe deficiency of vertebral body and sacral ossification, reduced rib number and cystic kidneys. In this study, however, we have demonstrated that variants in BMPER may cause a milder disorder, without renal anomalies, that is compatible with long-term survival. Four siblings, three males and one female, presented with severe congenital scoliosis associated with rib and vertebral malformations as well as strikingly delayed ossification of the pedicles. The female was stillborn from an unrelated cause. Stabilization of the scoliosis with expandable titanium rods was successful in the three boys, all of whom have short stature. An autosomal recessive mode of inheritance was hypothesized. Single nucleotide polymorphism microarray analysis was performed for three of the siblings to identify autosomal genes with shared allele patterns, suggesting possible linkage. Exome sequencing of one sibling was then performed. Rare variants were identified in 347 genes with shared alleles. Only one of these genes had bi-allelic variants in a gene strongly expressed in paraxial mesenchyme: BMPER, which is the cause of DSD, an autosomal recessive disorder. The disorder described herein could represent an attenuated form of DSD or could be designated a separate entity such as spondylopedicular dysplasia.
|
|---|---|
| Authors | Zheyuan Zong, Susan Tees, Firoz Miyanji, Clarissa Fauth, Christopher Reilly, Elena Lopez, Stephen Tredwell, Yigal Paul Goldberg, Allen Delaney, Patrice Eydoux, Margot Van Allen, Anna Lehman |
| Journal | Journal of human genetics (J Hum Genet) Vol. 60 Issue 12 Pg. 743-7 (Dec 2015) ISSN: 1435-232X [Electronic] England |
| PMID | 26467725 (Publication Type: Clinical Trial, Journal Article) |
| Chemical References |
|
| Topics |
|
Join CureHunter, for free Research Interface BASIC access!
Realize the full power of the drug-disease research graph!